Trial Profile
Economic Outcomes and treatment persistence of Generic Versus Brand-Name Drugs Used inTreating Peripheral Neuropathic Pain or Generalized Anxiety Disorder with Pregabalin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2018
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary) ; Pregabalin
- Indications Anxiety disorders; Neuropathic pain
- Focus Adverse reactions; Therapeutic Use
- 02 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research